Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Selective Serotonin Reuptake Inhibitors (SSRIs) for Autism Spectrum Disorders." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/457091/all/_________Selective_serotonin_reuptake_inhibitors__SSRIs__for_autism_spectrum_disorders______.
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/457091/all/_________Selective_serotonin_reuptake_inhibitors__SSRIs__for_autism_spectrum_disorders______. Accessed February 27, 2021.
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/457091/all/_________Selective_serotonin_reuptake_inhibitors__SSRIs__for_autism_spectrum_disorders______
Selective Serotonin Reuptake Inhibitors (SSRIs) for Autism Spectrum Disorders [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2021 February 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/457091/all/_________Selective_serotonin_reuptake_inhibitors__SSRIs__for_autism_spectrum_disorders______.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders
ID - 457091
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/457091/all/_________Selective_serotonin_reuptake_inhibitors__SSRIs__for_autism_spectrum_disorders______
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -